Launch week offerEnds in00h00m00s

annual Promonthly Pro

Victoria Niklas

Chief Medical Officer

United Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United Kingdom

About

Victoria Niklas is the Chief Medical Officer at Oak Hill Bio Ltd in the UK. Her research primarily focuses on respiratory morbidity, healthcare resource utilization, and the cost burden associated with extremely preterm birth, as evidenced by her recent work conducted in The Netherlands. Dr. Niklas is committed to advancing healthcare strategies that address the complexities of early neonatal care.

Articles (8)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2021

Collaborators (8)

Luca Bonadies

Researcher

University of Padova

ITALY

View details

Anne-Sylvie Ramelet

Professor of Nursing

University of Lausanne

SWITZERLAND

View details

Daniele De Luca

FRANCE

View details

Rangasamy Ramanathan

Division Chief of Neonatology, Professor

Cedars-Sinai Medical Center

UNITED STATES

View details

Lorenzo Zanetto

University of Padova

ITALY

View details

Alecia Nickless

University of Bristol

UNITED KINGDOM

View details

EUGENIO BARALDI

Full Professor

University of Padova

ITALY

View details

Matthew Douglass

Assistant Professor

University of Utah

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Victoria Niklas

Research Interests

Make your next move.

Explore related searches

About

Articles (8)

Advancing Neonatal Drug Development Through Industry–Academic Collaboration

Randomised Phase 2b trial of rhIGF-1/rhIGFBP-3 (OHB-607) for bronchopulmonary dysplasia prevention in preterm neonates: study protocol

Bronchopulmonary dysplasia and prematurity-associated lung disease: emerging therapies to improve lifelong respiratory outcomes

Developmental Therapeutics for Alveolar Generation and Regeneration: Implications for Bronchopulmonary Dysplasia and Prematurity-Associated Lung Disease

Translational Development of Physiologic IGF-1 Replacement for the Prevention of Bronchopulmonary Dysplasia

Recombinant human insulin-like growth factor 1 complex preserves lung development in mechanically ventilated preterm lambs

Expert review of CLABSI prevention in the NICU: supporting the transition of investigational drugs into clinical practice

Respiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The Netherlands

Collaborators (8)

Luca Bonadies

Anne-Sylvie Ramelet

Daniele De Luca

Rangasamy Ramanathan

Lorenzo Zanetto

Alecia Nickless

EUGENIO BARALDI

Matthew Douglass

Make your next move.